REPORT ID 6966

EMEA (Europe, Middle East and Africa) Bulk Drug Market Report 2017

Publish Date
1-Nov-17
Pages
124
Format
Electronic (PDF)

In this report, the EMEA Bulk Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Bulk Drug for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Bulk Drug market competition by top manufacturers/players, with Bulk Drug sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy?s Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine
    Biocon
    Johnson Matthey
    Hisun Pharmacy
    Cambrex
    Shandong Xinhua Pharmaceutical
    Lonza group
    Huahai Pharmaceutical
    Haerbin Pharmaceutical Group

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
    Vitamin
    Antibiotic
    Iohexol
    Hormone
    Amino Acid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Bulk Drug for each application, including
    Orthopedics Disease
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Bulk Drug Market Report 2017
1 Bulk Drug Overview
    1.1 Product Overview and Scope of Bulk Drug
    1.2 Classification of Bulk Drug
        1.2.1 EMEA Bulk Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Bulk Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Vitamin
        1.2.4 Antibiotic
        1.2.5 Iohexol
        1.2.6 Hormone
        1.2.7 Amino Acid
    1.3 EMEA Bulk Drug Market by Application/End Users
        1.3.1 EMEA Bulk Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Orthopedics Disease
        1.3.3 Others
    1.4 EMEA Bulk Drug Market by Region
        1.4.1 EMEA Bulk Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Bulk Drug (2012-2022)
        1.5.1 EMEA Bulk Drug Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Bulk Drug Revenue and Growth Rate (2012-2022)

2 EMEA Bulk Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Bulk Drug Market Competition by Players/Manufacturers
        2.1.1 EMEA Bulk Drug Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Bulk Drug Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Bulk Drug Sale Price by Players (2012-2017)
    2.2 EMEA Bulk Drug (Volume and Value) by Type/Product Category
        2.2.1 EMEA Bulk Drug Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Bulk Drug Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Bulk Drug Sale Price by Type (2012-2017)
    2.3 EMEA Bulk Drug (Volume) by Application
    2.4 EMEA Bulk Drug (Volume and Value) by Region
        2.4.1 EMEA Bulk Drug Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Bulk Drug Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Bulk Drug Sales Price by Region (2012-2017)

3 Europe Bulk Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Bulk Drug Sales and Value (2012-2017)
        3.1.1 Europe Bulk Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Bulk Drug Revenue and Growth Rate (2012-2017)
    3.2 Europe Bulk Drug Sales and Market Share by Type
    3.3 Europe Bulk Drug Sales and Market Share by Application
    3.4 Europe Bulk Drug Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Bulk Drug Sales Volume by Countries (2012-2017)
        3.4.2 Europe Bulk Drug Revenue by Countries (2012-2017)
        3.4.3 Germany Bulk Drug Sales and Growth Rate (2012-2017)
        3.4.4 France Bulk Drug Sales and Growth Rate (2012-2017)
        3.4.5 UK Bulk Drug Sales and Growth Rate (2012-2017)
        3.4.6 Russia Bulk Drug Sales and Growth Rate (2012-2017)
        3.4.7 Italy Bulk Drug Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Bulk Drug Sales and Growth Rate (2012-2017)

4 Middle East Bulk Drug (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Bulk Drug Sales and Value (2012-2017)
        4.1.1 Middle East Bulk Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Bulk Drug Revenue and Growth Rate (2012-2017)
    4.2 Middle East Bulk Drug Sales and Market Share by Type
    4.3 Middle East Bulk Drug Sales and Market Share by Application
    4.4 Middle East Bulk Drug Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Bulk Drug Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Bulk Drug Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Bulk Drug Sales and Growth Rate (2012-2017)
        4.4.4 Israel Bulk Drug Sales and Growth Rate (2012-2017)
        4.4.5 UAE Bulk Drug Sales and Growth Rate (2012-2017)
        4.4.6 Iran Bulk Drug Sales and Growth Rate (2012-2017)

5 Africa Bulk Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Bulk Drug Sales and Value (2012-2017)
        5.1.1 Africa Bulk Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Bulk Drug Revenue and Growth Rate (2012-2017)
    5.2 Africa Bulk Drug Sales and Market Share by Type
    5.3 Africa Bulk Drug Sales and Market Share by Application
    5.4 Africa Bulk Drug Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Bulk Drug Sales Volume by Countries (2012-2017)
        5.4.2 Africa Bulk Drug Revenue by Countries (2012-2017)
        5.4.3 South Africa Bulk Drug Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Bulk Drug Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Bulk Drug Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Bulk Drug Sales and Growth Rate (2012-2017)

6 EMEA Bulk Drug Manufacturers/Players Profiles and Sales Data
    6.1 Teva
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Bulk Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Teva Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Bulk Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Pfizer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Bulk Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Pfizer Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Johnson & Johnson
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Bulk Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Johnson & Johnson Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Mylan
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Bulk Drug Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Mylan Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 North China Pharmaceutical Group
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Bulk Drug Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 North China Pharmaceutical Group Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Dr. Reddy?s Laboratories
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Bulk Drug Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Dr. Reddy?s Laboratories Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Roche
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Bulk Drug Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Roche Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Aurobindo pharma
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Bulk Drug Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Aurobindo pharma Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sun Pharmaceutical Industries
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Bulk Drug Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sun Pharmaceutical Industries Bulk Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Boehringer Ingelheim GmbH
    6.12 Bayer
    6.13 BASF
    6.14 DSM
    6.15 Zhejiang Medicine
    6.16 Biocon
    6.17 Johnson Matthey
    6.18 Hisun Pharmacy
    6.19 Cambrex
    6.20 Shandong Xinhua Pharmaceutical
    6.21 Lonza group
    6.22 Huahai Pharmaceutical
    6.23 Haerbin Pharmaceutical Group

7 Bulk Drug Manufacturing Cost Analysis
    7.1 Bulk Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Bulk Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Bulk Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Bulk Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Bulk Drug Market Forecast (2017-2022)
    11.1 EMEA Bulk Drug Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Bulk Drug Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Bulk Drug Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Bulk Drug Price and Trend Forecast (2017-2022)
    11.2 EMEA Bulk Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Bulk Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Bulk Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Bulk Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Bulk Drug Sales Forecast by Type (2017-2022)
    11.7 EMEA Bulk Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer